BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19898437)

  • 21. Clinical experience with Hedgehog pathway inhibitors.
    Low JA; de Sauvage FJ
    J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vismodegib: a review.
    Ruiz-Salas V; Alegre M; López-Ferrer A; Garcés JR
    Actas Dermosifiliogr; 2014 Oct; 105(8):744-51. PubMed ID: 24359667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vismodegib.
    Meiss F; Andrlová H; Zeiser R
    Recent Results Cancer Res; 2018; 211():125-139. PubMed ID: 30069764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vismodegib: a guide to its use in locally advanced or metastatic basal cell carcinoma.
    Lyseng-Williamson KA; Keating GM
    Am J Clin Dermatol; 2013 Feb; 14(1):61-4. PubMed ID: 23329081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GDC-0449--targeting the hedgehog signaling pathway.
    Dierks C
    Recent Results Cancer Res; 2010; 184():235-8. PubMed ID: 20072843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma.
    Proctor AE; Thompson LA; O'Bryant CL
    Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
    Lear JT
    N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
    [No Abstract]   [Full Text] [Related]  

  • 28. Vismodegib: a promising drug in the treatment of basal cell carcinomas.
    Dirix L; Rutten A
    Future Oncol; 2012 Aug; 8(8):915-28. PubMed ID: 22894666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vismodegib in advanced basal-cell carcinoma.
    Babacan T; Sarici F; Altundag K
    N Engl J Med; 2012 Sep; 367(10):969-70; author reply 970. PubMed ID: 22931270
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancer stem cells in the crosshairs.
    Schmidt C
    Cancer Discov; 2012 May; 2(5):384. PubMed ID: 22588862
    [No Abstract]   [Full Text] [Related]  

  • 31. Hedgehog Pathway Inhibition.
    Sekulic A; Von Hoff D
    Cell; 2016 Feb; 164(5):831. PubMed ID: 26919418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vismodegib in advanced basal-cell carcinoma.
    Henkin RI
    N Engl J Med; 2012 Sep; 367(10):970; author reply 970-1. PubMed ID: 22931271
    [No Abstract]   [Full Text] [Related]  

  • 33. Hedgehog-like moustache trichomegaly during treatment with vismodegib.
    Riera-Monroig J; Combalia A; Rodríguez A; Alós L; Mangas C; Ferrando J; Carrera C
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):e11-e13. PubMed ID: 31393645
    [No Abstract]   [Full Text] [Related]  

  • 34. Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease.
    Radojcic V; Pletneva M; Lee CJ; Ivcevic S; Sarantopoulos S; Couriel D
    Br J Haematol; 2021 Oct; 195(2):e120-e122. PubMed ID: 34142367
    [No Abstract]   [Full Text] [Related]  

  • 35. Emerging treatments and signaling pathway inhibitors.
    Tang JY; Marghoob AA
    Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S14-8. PubMed ID: 22177102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hedgehog inhibitors: a patent review (2013 - present).
    Xin M
    Expert Opin Ther Pat; 2015 May; 25(5):549-65. PubMed ID: 25726713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of chemoresistance in a metastatic basal cell carcinoma patient after complete response to hedgehog pathway inhibitor vismodegib (GDC-0449).
    Meani RE; Lim SW; Chang AL; Kelly JW
    Australas J Dermatol; 2014 Aug; 55(3):218-21. PubMed ID: 25117162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature.
    Campione E; Di Prete M; Lozzi F; Lanna C; Spallone G; Mazzeo M; Cosio T; Rapanotti C; Dika E; Gaziano R; Orlandi A; Bianchi L
    Chemotherapy; 2020; 65(1-2):2-10. PubMed ID: 32777789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hedgehog signaling and therapeutics in pancreatic cancer.
    Kelleher FC
    Carcinogenesis; 2011 Apr; 32(4):445-51. PubMed ID: 21186299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.
    Cirrone F; Harris CS
    Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.